SMAD3 and neoplasm: The stent protein PDLIM5 (PDZ and LIM structural domain protein 5, ENH) is a novel regulator of SMAD3 stability and critically promotes TGF-β signalling and tumour progression by maintaining SMAD3 stability in NSCLC [98].